---
figid: PMC7427806__41389_2020_259_Fig4_HTML
figlink: pmc/articles/PMC7427806/figure/Fig4/
number: F4
caption: A schematic representation of the signaling pathways upregulated in the Tfh
  lymphoma cells is shown. a AITL-like mouse model based on adaptive transfer of Tet2
  invalidated mature CD4 T cells transduced with a retroviral vector expression RhoAG17V
  (ref. ). b AITL-like mouse model based on transplantation of the BM of Tet2 KO mice,
  transduced with a retroviral vector coding for mutated RhoAG17V (ref. ). c AITL-like
  mouse model based on transgenic mice, in which Tet2 is invalidated in the whole
  hematopoietic system while RhoAG17V under the control of a CD4-specific promoter
  is exclusively expressed in CD4 T cells. The therapeutic agents (Everiolimus and
  Duvelisib) interfering with the PI3K-AKT-mTORc1 pathway are indicated.
pmcid: PMC7427806
papertitle: 'New preclinical models for angioimmunoblastic T-cell lymphoma: filling
  the GAP.'
reftext: Rana Mhaidly, et al. Oncogenesis. 2020 Aug;9(8):73.
pmc_ranked_result_index: '69408'
pathway_score: 0.933947
filename: 41389_2020_259_Fig4_HTML.jpg
figtitle: 'New preclinical models for angioimmunoblastic T-cell lymphoma: filling
  the GAP'
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7427806__41389_2020_259_Fig4_HTML.html
  '@type': Dataset
  description: A schematic representation of the signaling pathways upregulated in
    the Tfh lymphoma cells is shown. a AITL-like mouse model based on adaptive transfer
    of Tet2 invalidated mature CD4 T cells transduced with a retroviral vector expression
    RhoAG17V (ref. ). b AITL-like mouse model based on transplantation of the BM of
    Tet2 KO mice, transduced with a retroviral vector coding for mutated RhoAG17V
    (ref. ). c AITL-like mouse model based on transgenic mice, in which Tet2 is invalidated
    in the whole hematopoietic system while RhoAG17V under the control of a CD4-specific
    promoter is exclusively expressed in CD4 T cells. The therapeutic agents (Everiolimus
    and Duvelisib) interfering with the PI3K-AKT-mTORc1 pathway are indicated.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TET2
  - RHOA
  - CD4
  - AKT2
  - AKT3
  - AKT1
  - FOXO1
  - ICOS
  - ICOSLG
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - MTOR
  - Everolimus
  - BM
genes:
- word: Tet2
  symbol: TET2
  source: hgnc_symbol
  hgnc_symbol: TET2
  entrez: '54790'
- word: RhoA
  symbol: RhoA
  source: hgnc_alias_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: ;Tet2
  symbol: TET2
  source: hgnc_symbol
  hgnc_symbol: TET2
  entrez: '54790'
- word: CD4,rom-RhoAs17V
  symbol: CD4
  source: hgnc_symbol
  hgnc_symbol: CD4
  entrez: '920'
- word: RhoA
  symbol: RhoA
  source: hgnc_alias_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: Tet2*
  symbol: TET2
  source: hgnc_symbol
  hgnc_symbol: TET2
  entrez: '54790'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Fox01
  symbol: FOXO1
  source: hgnc_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: Fox01
  symbol: FOXO1
  source: hgnc_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: Tet2*
  symbol: TET2
  source: hgnc_symbol
  hgnc_symbol: TET2
  entrez: '54790'
- word: Tet2
  symbol: TET2
  source: hgnc_symbol
  hgnc_symbol: TET2
  entrez: '54790'
- word: CD4+
  symbol: CD4
  source: hgnc_symbol
  hgnc_symbol: CD4
  entrez: '920'
- word: CD4+
  symbol: CD4
  source: hgnc_symbol
  hgnc_symbol: CD4
  entrez: '920'
- word: ICOS
  symbol: ICOS
  source: hgnc_symbol
  hgnc_symbol: ICOS
  entrez: '29851'
- word: ICOSL
  symbol: ICOSL
  source: hgnc_prev_symbol
  hgnc_symbol: ICOSLG
  entrez: '23308'
- word: RhoA
  symbol: RhoA
  source: hgnc_alias_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Tet2*
  symbol: TET2
  source: hgnc_symbol
  hgnc_symbol: TET2
  entrez: '54790'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Tet2/
  symbol: TET2
  source: hgnc_symbol
  hgnc_symbol: TET2
  entrez: '54790'
chemicals:
- word: Everolimus
  source: MESH
  identifier: C107135
- word: BM
  source: MESH
  identifier: C038672
diseases: []
figid_alias: PMC7427806__F4
redirect_from: /figures/PMC7427806__F4
figtype: Figure
---
